Opendata, web and dolomites
H2020 projects about "dopamine"
The page lists 42 projects related to the topic "dopamine".
| # | |||
|---|---|---|---|
| 1 | FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone | 2015 |
| 2 | CoordinatedDopamine | Coordination of regional dopamine release in the striatum during habit formation and compulsive behaviour | 2015 |
| 3 | PROPHETIC | PROPHETIC:An innovating Personal Healthcare Service for a holistic remote management and treatment of Parkinson patients. | 2015 |
| 4 | SynChI | Striatal cholinergic cell assemblies in movement disorders | 2015 |
| 5 | CircaDopamine | The Role of Dopamine in the Regulation of Sleep and Circadian Rhythms | 2015 |
| 6 | MediVAC | Bio-sustainable production of natural medicines from Vitex | 2015 |
| 7 | MEMBRANEPROT | Membrane proteins – development of new computational approaches and its application to G-Protein Coupled Receptors | 2016 |
| 8 | eADAM | Ultra-small electrochemical aptasensors for specific dopamine real-time monitoring | 2016 |
| 9 | ROSNPD | Selective vulnerability of neuronal degeneration in Parkinson’s disease: the load of routine behaviour | 2016 |
| 10 | PROGSY | Prosaposin and GPR37 in synucleinopathies | 2015 |
| 11 | WipeOutFear | How the Brain Learns to Forget - The Neural Signature of Fear Memory Erasure | 2015 |
| 12 | MotMotLearn | Motivating Motor Learning: The Role of Reward, Punishment and Dopamine | 2015 |
| 13 | CoCA | Comorbid Conditions of Attention deficit / hyperactivity disorder | 2016 |
| 14 | DeBoRA | Dopamine and Bone Metabolism in Rheumatoid Arthritis | 2016 |
| 15 | GENEVA | Unravelling how GENEtic VAriation in attentional control contributes to working memory capacity | 2016 |
| 16 | iRELaTE | Immune Response and Social Cognition in Schizophrenia | 2016 |
| 17 | PERCEPT | The mind's eye: How expectation and attention shape perception | 2016 |
| 18 | CholAminCo | Synergy and antagonism of cholinergic and dopaminergic systems in associative learning | 2017 |
| 19 | EPOFFSPRING | Epigenetic mechanisms underlying the influence of paternal drug experience on offspring behavior | 2017 |
| 20 | DRiveR | How does dopamine link QMP with reproductive repression to mediate colony harmony and productivity in the honeybee? | 2018 |
| 21 | Brain2Bee | How dopamine affects social and motor ability - from the human brain to the honey bee | 2018 |
| 22 | ParallelMemories | Cooperative and competitive parallel memory units for choice behaviors | 2018 |
| 23 | DOPANF | Dopaminergic midbrain modulations by (adaptive) neurofeedback | 2018 |
| 24 | DYCOCIRC | Basal ganglia circuit mechanisms underlying dynamic cognitive behavior | 2018 |
| 25 | TOLKEDA | Modulating brain structural plasticity versus neurodegeneration via a novel mechanism involving neurotrophins and dopamine, Tolls and Kek truncated-Trk-like receptors in Drosophila. | 2018 |
| 26 | SOCIALBRAINCIRCUITS | Neuroanatomical substrates of social deficit in a mouse model of 22q11 deletion syndrome | 2018 |
| 27 | TREAT-PD | Patient-specific treatment for Parkinson's disease using reprogrammed skin cells | 2018 |
| 28 | GONDOLA | Automated Mechanical Peripheral Stimulation for motor rehabilitation in people living with Parkinson’s Disease (PD) | 2018 |
| 29 | FutureTrophicFactors | Elucidating therapeutic effects and mode of action of future trophic factorsin ALS and Parkinson’s disease | 2019 |
| 30 | INTEGRATE | An integrated hypothesis for cognitive and positive symptoms in schizophrenia | 2018 |
| 31 | SCAMPICITY | cAMP-dependend plasticity of striatal projection neurons in health and disease | 2019 |
| 32 | AmygdalaNeuroMod | Unraveling the combinatorial logic of amygdala neuromodulation in decision-making and learning. | 2020 |
| 33 | HYMNS | Hypothalamic Modulation of Neocortical States | 2020 |
| 34 | RememberEx | Human Subcortical-Cortical Circuit Dynamics for Remembering the Exceptional | 2019 |
| 35 | THERAPE | Novel blood-brain barrier permeable CDNF-derived therapeutic peptides for the protection and regeneration of dopamine neurons | 2019 |
| 36 | OPIOIDREWARD | How distress alters opioid drug effects and abuse liability | 2019 |
| 37 | INSENSE | Incentive salience in human cognition during health and disorder | 2019 |
| 38 | AND-PD | COMORBIDITY MECHANISMS OF ANXIETY AND PARKINSON’S DISEASE | 2020 |
| 39 | GONOGO | Multi-layered integration of motivated actions and their outcomes in basal ganglia circuits | 2020 |
| 40 | MotiVTA | Characterizing opposing BNST to VTA circuits that differentially regulate motivation and individual responses to stress | 2020 |
| 41 | BMPARK | Development of BMP2 Neurotrophic Therapy for Parkinson’s Disease | 2020 |
| 42 | HT4PD | The role of the serotonin 5-HT4 receptor in motor and non-motor symptoms of Parkinson’s disease | 2021 |